Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialisation of life-transforming therapeutic products.
Their new 215,000 sq. ft. state of the art facility in Blanchardstown, West Dublin is the first ever Alexion biologics manufacturing facility outside the United States.
This €450 million investment is one of the largest investments in healthcare in the history of the Irish state.
Built in two phases, phase one spans over 129,000 sq.ft. and incorporates the main office and administration building. The second phase, featuring a 98 ft. high shard, was built as a bulk drug substance manufacturing facility.